Hailey-Hailey Disease (Benign Familial Pemphigus, Investigational Adjunct)
Investigational adjunct for refractory Hailey-Hailey disease; topical corticosteroids, topical antibiotics, topical calcineurin inhibitors, oral antibiotics, and (refractory) botulinum toxin or surgical interventions remain evidence-based.
Resumen para el Paciente
- ¿Está esto autorizado por FDA para este uso?
- Not FDA-cleared for Hailey-Hailey disease (benign familial pemphigus). FDA cleared medicinal leeches only for venous congestion in microsurgical reconstruction (K040187, June 2004). Use here is Tier C investigational.
- ¿Qué evidencia existe?
- Tier C (investigational). Hailey-Hailey is a rare autosomal-dominant disorder of ATP2C1 affecting intercellular adhesion. Evidence-based management is topical and intralesional corticosteroid for flares, topical and oral antibiotics for secondary bacterial infection, topical or oral antifungal for superimposed candidiasis, and for severe refractory disease ablative laser, botulinum toxin injection (reduces sweat that triggers flares), naltrexone, dapsone, or surgical excision and grafting of severely affected skin.
- Riesgos principales
- Bleeding from each bite site for 6 to 10 hours after the leech detaches
- Iron-deficiency anemia from cumulative blood loss across multiple sessions
- Aeromonas hydrophila wound infection from leech gut bacteria (uncommon outside reconstructive surgery, but possible)
- Allergic reaction to leech saliva (rare; ranges from local itching to anaphylaxis)
- Permanent Y-shaped bite-mark scars or hyperpigmentation at attachment sites
- Local pain, bruising, swelling, or itching for 1 to 3 days after each session
- Worsening of intertriginous fragility — Hailey-Hailey skin tears easily
- Bacterial or fungal superinfection of leech bite sites
- Triggering acantholysis spreading from bite sites
- Quién no debería considerar esto
- Patients with active superinfection (bacterial or fungal — treat first)
- Patients who have not tried topical corticosteroid, antimicrobials, and botulinum toxin
- Patients with severe refractory disease who are candidates for ablative laser or surgery
- Anyone on blood thinners such as warfarin, apixaban, rivaroxaban, dabigatran, heparin, or daily aspirin used for medical reasons
- People with hemophilia or any other inherited bleeding disorder
- Patients with severe anemia (hemoglobin under 10 g/dL)
- People with an active infection at the planned application site
- Qué preguntar a su clínico
- Has my diagnosis been confirmed and superinfection ruled out by culture?
- Have I tried botulinum toxin, naltrexone, or ablative laser?
- What is the risk that bites worsen the fragility and trigger spreading lesions?
- How will superinfection of bite sites be prevented?
- What is the published evidence base for leeches in Hailey-Hailey?
- What is the plan if a flare extends from bite sites?
- Cuándo buscar atención urgente
- Bleeding from a bite site that soaks through more than one dressing per hour
- Bleeding that continues more than 24 hours after the leech detached
- Spreading redness, warmth, swelling, pus, or red streaks around any bite site
- Fever over 38.0 C / 100.4 F, chills, or feeling suddenly unwell after a session
- Hives, facial or tongue swelling, throat tightness, or any difficulty breathing
- Sudden weakness, dizziness, fast heart rate, or fainting (possible severe blood loss)
- Rapidly spreading raw or eroded skin with severe pain
- Fever with skin tenderness suggesting Staphylococcal scalded skin or cellulitis
- Vesicular eruption near affected skin (rule out eczema herpeticum)
Qué NO significa esto
- It does not mean leech therapy is FDA-cleared for Hailey-Hailey — the only FDA clearance is venous congestion in microsurgical reconstruction (K040187, June 2004).
- It does not address the underlying ATP2C1 genetic defect.
- It does not replace botulinum toxin, ablative laser, or other established refractory-disease therapies.
- It may worsen skin fragility and trigger spreading lesions.
- It does not have controlled-trial evidence in this rare disease.
Referencias cruzadas de seguridad
Clinical Profile
- Category
- dermatological
- ICD-10
- Q82.8
- Safety tier
- high
Evidence Summary
Hailey-Hailey disease (benign familial pemphigus) is an autosomal dominant acantholytic disorder caused by ATP2C1 mutations, producing recurrent flaccid vesicles and macerated erosions in intertriginous areas (axillae, groin, neck, perianal). Evidence-based stepwise management: friction and sweat reduction, topical mid-potency corticosteroids and topical antibiotics for flares, topical calcineurin inhibitors as steroid-sparing agents, oral antibiotics or antivirals for superinfection, and (refractory) intradermal botulinum toxin, ablative laser, dermabrasion, or surgical excision and grafting. No published controlled trials of hirudotherapy exist for Hailey-Hailey disease. Intertriginous skin is moist, fragile, and frequently superinfected with bacteria or HSV, making leech placement both technically difficult and high-risk for triggering acantholysis (a Koebner-like response).
Treatment specifics
How many leeches, where they are placed, how long a session lasts, and whether to repeat are clinical decisions made by a qualified provider under institutional protocol — not something to self-administer. Discuss the specifics with a clinician experienced in medicinal leech therapy. (Clinicians: switch the audience selector in the top bar to “Clinician” to view protocol detail.)
Contraindications
- Active anticoagulant therapy (warfarin INR >2.0, DOACs, heparin)
- Hemophilia or other bleeding disorder
- Severe anemia (Hb <10 g/dL)
- Active bacteremia or sepsis
- Known hypersensitivity to leech salivary proteins
- Pregnancy (relative — first/third trimester)
- Immunocompromised state with severe neutropenia
- Intertriginous placement (axilla, groin, inframammary, neck flexure) — absolute
- Active bacterial, fungal, or HSV superinfection
- Recent botulinum toxin or ablative laser treatment
- Koebner phenomenon — any skin trauma may trigger new acantholysis
Related Conditions
Livedo Reticularis
Investigational use for primary livedo reticularis; very limited evidence. Secondary causes (lupus, APLAS) require rheumatology referral.
Lipodermatosclerosis
Investigational use for chronic lipodermatosclerosis; small case series suggest softening of fibrotic gaiter-area skin changes.
Insulin Injection Lipohypertrophy
Investigational use to soften and remodel insulin injection-related lipohypertrophy nodules; very limited evidence.
Androgenic Alopecia
Investigational use for androgenic alopecia; mechanism via local scalp perfusion improvement. Single-arm series only.